Investing.com – Pfizer (NYSE:) (NYSE: PFE) reported third quarter EPS of $1.78, $0.34 better than the analyst estimate of $1.44. Revenue for the quarter came in at $22.6B versus the consensus estimate of $21.33B.
Pfizer’s stock price closed at $46.55. It is down -6.64% in the last 3 months and up 2.42% in the last 12 months.
Pfizer saw 1 positive EPS revisions and 13 negative EPS revisions in the last 90 days. See Pfizer’s stock price’s past reactions to earnings here.
According to InvestingPro, Pfizer’s Financial Health score is “excellent performance”.
Check out Pfizer’s , and Pfizer’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Story Credit: investing.com